← back to search

Ewan Forrest

Glasgow Royal Infirmary · GB
🔎 Find collaborators in Epidemiology · Hepatology →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Epidemiology · Hepatology
Research interest
Research interests include Liver Disease Diagnosis and Treatment, Liver Disease and Transplantation, Alcohol Consumption and Health Effects, and Alcoholism and Thiamine Deficiency.
h-index
34
citations
6,610
works
258
NIH funding
primary concept
Medicine
email

Recent publications

IL-1 Signal Inhibition in Alcohol-Related Hepatitis: A Randomized, Double-Blind, Placebo-Controlled Trial of Canakinumab
Clinical Gastroenterology and Hepatology 2024cited by 21position: middledoi
Diet modifies the association between alcohol consumption and severe alcohol-related liver disease incidence
Nature Communications 2024cited by 17position: middledoi
Global disparities in mortality and liver transplantation in hospitalised patients with cirrhosis: a prospective cohort study for the CLEARED Consortium
˜The œLancet. Gastroenterology & hepatology 2023cited by 29position: middledoi
Evaluating the Role of Antibiotics in Patients Admitted to Hospital With Decompensated Cirrhosis: Lessons From the ATTIRE Trial.
2023cited by 21position: contributordoi
The Liverpool alcohol-related liver disease algorithm identifies twice as many emergency admissions compared to standard methods when applied to Hospital Episode Statistics for England.
2023cited by 12position: contributordoi
In severe alcohol-related hepatitis, acute kidney injury is prevalent, associated with mortality independent of liver disease severity, and can be predicted using IL-8 and micro-RNAs.
2023cited by 9position: contributordoi
Associations of muscle mass and grip strength with severe NAFLD: A prospective study of 333,295 UK Biobank participants
Journal of Hepatology 2022cited by 116position: contributordoi
The MELD Score Is Superior to the Maddrey Discriminant Function Score to Predict Short-Term Mortality in Alcohol-Associated Hepatitis: A Global Study.
2022cited by 64position: contributordoi
Association of gamma-glutamyltransferase levels with total mortality, liver-related and cardiovascular outcomes: A prospective cohort study in the UK Biobank
eClinicalMedicine 2022cited by 30position: contributordoi
Correction to: The MELD Score Is Superior to the Maddrey Discriminant Function Score to Predict Short-Term Mortality in Alcohol-Associated Hepatitis: A Global Study
The American Journal of Gastroenterology 2022cited by 20position: middledoi
The Role of Micronutrients in the Pathogenesis of Alcohol-Related Liver Disease.
2022cited by 12position: contributordoi
Carvedilol versus endoscopic band ligation for secondary prophylaxis of variceal bleeding-long-term follow-up of a randomised control trial.
2022cited by 10position: contributordoi
Changes in Hospital Discharges with Alcohol-Related Liver Disease in a Gastroenterology and General Medical Unit Following the Introduction of Minimum Unit Pricing of Alcohol: The GRI Q4 Study.
2022cited by 5position: contributordoi
Effect of COVID-19 on presentations of decompensated liver disease in Scotland.
2022cited by 3position: contributordoi
Audit of medical (non-targeted) liver biopsy specimen quality, pathology reporting and effect on patient management.
2022cited by 2position: contributordoi
Letter: the value of quality liver biopsy before initiation of corticosteroids for severe alcoholic hepatitis-authors' reply.
2022cited by 0position: contributordoi
A Randomized Trial of Albumin Infusions in Hospitalized Patients with Cirrhosis.
2021cited by 229position: contributordoi
The MELD Score Is Superior to the Maddrey Discriminant Function Score to Predict Short-Term Mortality in Alcohol-Associated Hepatitis: A Global Study
The American Journal of Gastroenterology 2021cited by 82position: middledoi
Carvedilol is associated with improved survival in patients with cirrhosis: a long-term follow-up study.
2021cited by 39position: contributordoi
The diagnostic and prognostic significance of liver histology in alcoholic hepatitis.
2021cited by 22position: contributordoi
IL-1 Signal Inhibition In Alcoholic Hepatitis (ISAIAH): a study protocol for a multicentre, randomised, placebo-controlled trial to explore the potential benefits of canakinumab in the treatment of alcoholic hepatitis.
2021cited by 16position: contributordoi
Effect of Hepatocellular Carcinoma Surveillance Programmes on Overall Survival in a Mixed Cirrhotic UK Population: A Prospective, Longitudinal Cohort Study.
2021cited by 15position: contributordoi
Targeted Albumin Therapy Does Not Improve Short-Term Outcome in Hyponatremic Patients Hospitalized With Complications of Cirrhosis: Data From the ATTIRE Trial.
2021cited by 12position: contributordoi
Multicenter cohort study of patients with buried bumper syndrome treated endoscopically with a novel, dedicated device.
2021cited by 8position: contributordoi
Letter: the diagnostic and prognostic significance of liver histology in alcoholic hepatitis-authors' reply.
2021cited by 3position: contributordoi
Genome-Wide Association Study for Alcohol-Related Cirrhosis Identifies Risk Loci in MARC1 and HNRNPUL1.
2020cited by 70position: contributordoi
Randomised clinical trial: standard of care versus early-transjugular intrahepatic porto-systemic shunt (TIPSS) in patients with cirrhosis and oesophageal variceal bleeding.
2020cited by 52position: contributordoi
Recent advances in alcoholic hepatitis.
2020cited by 4position: contributordoi
Use of MELD scores in alcoholic hepatitis.
2020cited by 2position: contributordoi
Alcohol-related liver disease results in significant long-term mortality irrespective of the presence of steatohepatitis.
2020cited by 0position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 5 papers (2019–2023)Mark Thursz · Imperial College London5 papers (2019–2023)Rob Goldin · St. Mary's Hospital4 papers (2021–2022)David Young · University of Strathclyde3 papers (2019–2022)Stephen Ryder · Imperial College Healthcare NHS Trust2 papers (2019–2021)Ashwin D. Dhanda · University of Plymouth2 papers (2019–2023) · 2 papers (2022–2022) · 2 papers (2023–2023)Richard Parker · University of Leeds2 papers (2019–2023)John Dillon · Mayo Clinic2 papers (2020–2022)Sharon Hutchinson · University of Antwerp1 papers (2020–2020)Pierre‐Emmanuel Rautou · Inserm1 papers (2022–2022)John Ramage · Hampshire Hospitals NHS Foundation Trust1 papers (2021–2021)Florian Eyer · Washington Poison Center1 papers (2020–2020)Jill P. Pell · University of Glasgow1 papers (2024–2024)Ziyi Zhou · Huazhong University of Science and Technology1 papers (2024–2024)Ulrich Spengler · University of Bonn1 papers (2020–2020)Pierre Deltenre · Université Paris Cité1 papers (2020–2020)John C. Mathers · NIHR Newcastle Biomedical Research Centre1 papers (2024–2024)Peter Hayes · Edinburgh Royal Infirmary1 papers (2021–2021)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Epidemiology · Hepatology →